Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern
- PMID: 32583281
- DOI: 10.1007/s11033-020-05592-3
Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in humans, with less than 5% 5-year survival rate. PDAC is characterized by a small number of recurrent mutations, including KRAS, CDKN2A, TP53, and SMAD4 and a long "tail" of infrequent mutated genes. Most of the studies have been performed in US and European populations, so new studies are needed to describe the mutational landscape of these tumors in other cohorts. The present study analyzed the exome and transcriptome of four PDAC tumors from Mexican patients. We found a paucity of the previously described recurrent mutations, with mutations in only three genes (HERC2, CNTNAP2 and HMCN1) previously reported in PDAC with a frequency > 1%. In addition, we discovered several recurrent putative copy number aberrations in SKP2, BRAF, CSSF1R, FOXE1, JAK2 and MET genes and in genes previously reported as putative drivers in PDAC, including KRAS, SF3B1, BRAF, MYC and MET. Although a larger cohort is needed to validate these findings, our results could be pointing toward potential differences in contributing factors for PDAC in Latin-American populations.
Keywords: Exome sequencing; PDAC.
Similar articles
-
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.BMC Cancer. 2022 Feb 18;22(1):186. doi: 10.1186/s12885-022-09279-9. BMC Cancer. 2022. PMID: 35180847 Free PMC article.
-
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.Cancer. 2020 Sep 1;126(17):3939-3949. doi: 10.1002/cncr.33038. Epub 2020 Jun 23. Cancer. 2020. PMID: 32573775 Free PMC article.
-
Clinical Effect of Driver Mutations of KRAS, CDKN2A/P16, TP53, and SMAD4 in Pancreatic Cancer: A Meta-Analysis.Genet Test Mol Biomarkers. 2020 Dec;24(12):777-788. doi: 10.1089/gtmb.2020.0078. Genet Test Mol Biomarkers. 2020. PMID: 33347393
-
The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820920969. doi: 10.1177/1533033820920969. Technol Cancer Res Treat. 2020. PMID: 32372692 Free PMC article. Review.
-
[Will molecular diagnostics become established in pancreatic pathology?].Pathologe. 2013 Nov;34 Suppl 2:214-20. doi: 10.1007/s00292-013-1865-z. Pathologe. 2013. PMID: 24196616 Review. German.
Cited by
-
The high expression of FOXE1 in colorectal cancer predicts a promising prognosis: a retrospective study.Clin Exp Med. 2023 Nov;23(7):3995-4001. doi: 10.1007/s10238-023-01096-z. Epub 2023 Jun 6. Clin Exp Med. 2023. PMID: 37278933
-
The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.Int J Mol Sci. 2021 Jun 15;22(12):6374. doi: 10.3390/ijms22126374. Int J Mol Sci. 2021. PMID: 34203589 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous